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Abstract
The influence of magnetic resonance imaging (MRI) devices at
high field strengths on living tissues is unknown. We
investigated the effects of a 3-tesla electromagnetic field (EMF)
on the biosynthetic activity of bovine articular cartilage. Bovine
articular cartilage was obtained from juvenile and adult animals.
Whole joints or cartilage explants were subjected to a pulsed 3-
tesla EMF; controls were left unexposed. Synthesis of sulfated
glycosaminoglycans (sGAGs) was measured by using
[35S]sulfate incorporation; mRNA encoding the cartilage
markers aggrecan and type II collagen, as well as IL-1β, were
analyzed by RT–PCR. Furthermore, effects of the 3-tesla EMF
were determined over the course of time directly after exposure
(day 0) and at days 3 and 6. In addition, the influence of a 1.5-
tesla EMF on cartilage sGAG synthesis was evaluated.
Chondrocyte cell death was assessed by staining with Annexin
V and TdT-mediated dUTP nick end labelling (TUNEL).
Exposure to the EMF resulted in a significant decrease in
cartilage macromolecule synthesis. Gene expression of both
aggrecan and IL-1β, but not of collagen type II, was reduced in
comparison with controls. Staining with Annexin V and TUNEL
revealed no evidence of cell death. Interestingly, chondrocytes
regained their biosynthetic activity within 3 days after exposure,
as shown by proteoglycan synthesis rate and mRNA expression
levels. Cartilage samples exposed to a 1.5-tesla EMF remained
unaffected. Although MRI devices with a field strength of more
than 1.5 T provide a better signal-to-noise ratio and thereby
higher spatial resolution, their high field strength impairs the
biosynthetic activity of articular chondrocytes in vitro. Although
this decrease in biosynthetic activity seems to be transient,
articular cartilage exposed to high-energy EMF may become
vulnerable to damage.
Introduction
The imaging of articular cartilage in clinical practice relies
mainly on conventional radiography and ultrasound. In joint
disorders with concomitant cartilage damage, imaging tech-
niques that visualize the whole cartilage are desirable for diag-
nostic purposes. Magnetic resonance imaging (MRI) has been
proposed to serve such an aim, because the MRI technique is
unparalleled in its capacity to delineate the morphology and
composition of articular cartilage [1].
In contrast to the planar images provided by conventional radi-
ographic techniques, MRI permits the assessment of the
whole articular surface of a joint. This allows one to evaluate
cartilage defects and thinning in regions of the joint not visible
to radiography or ultrasound, which also provides greater sen-
sitivity to change. Currently, 1.5-tesla standard MRI devices
are widely used; however, to improve the signal-to-noise ratio
that would ultimately result in an increase in spatial resolution
and contrast [2], higher field strengths of 3 T and more have
been introduced and may replace 1.5-tesla machines in the
near future.
However, MRI techniques require patients to be exposed to an
intense electromagnetic field (EMF) of a strength not
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previously encountered. As radio frequency energy is
absorbed more effectively at higher frequencies [3], safety
concerns regarding possible interactions between high-
energy EMFs of at least 3 T and living tissues were raised.
Potential mechanisms could be a distortion in the orientation
of macromolecules and membranes, effects on the conducti-
bility of peripheral nerves, electrocardiographic or electroen-
cephalographic alterations or effects on blood rheology;
however, the vast majority of the scans have been performed
without any evidence of sequelae to the patients and therefore
the technique has been considered to be safe [4]. Neverthe-
less, there is a lack of studies on the direct influence of high-
energy EMFs on living tissues including articular cartilage. In
contrast, investigations of low-energy EMFs in vitro showed a
direct stimulatory effect on cartilage matrix synthesis [5,6] and
cell proliferation [7,8]. The clinical efficacy of these EMFs has
also been shown in bone fracture healing [9,10]; moreover,
low-energy EMFs have been used in the non-invasive therapy
of degenerative joint diseases [11,12].
On the basis of these observations we wondered whether
high-energy EMFs would have similar effects on the biosyn-
thetic activity of articular cartilage. In the present study we
investigated the influence of a 3-tesla EMF on the matrix bio-
synthesis of chondrocytes derived from bovine articular
cartilage.
Materials and methods
Tissue culture and exposure to EMF
Hooves from 15 three-month-old calves and 8 adult steers
were obtained from a local slaughterhouse (Steininger,
Simondsfeld, Austria). Because the hooves and the metacar-
pophalangeal joints are not used in meat processing and con-
stitute waste material, no ethics committee approval was
required. Metacarpophalangeal joints were prepared by the
removal of skin and appendages.
Experiments were performed by exposing either whole joints
or cartilage explant cultures to the pulsed EMF. The samples
were divided into two groups (control group and 'pulsed EMF'
group). The specimens of the 'pulsed EMF' group were sub-
jected either to a 3-tesla MRI device (Medical 3T MedSpec;
Bruker, Ettingen, Germany) or a 1.5-tesla MRI device (MAG-
NETOM Vision/Plus; Siemens, Erlangen, Germany).
For whole-joint exposure, joints from juvenile animals were
wrapped in plastic wrap. Thereafter the joints of the 'pulsed
EMF' group were subjected to a pulsed EMF (constant 3-tesla
and additional 0.0135-tesla pulsed field, pulse rate 0.5 s) for
the duration of a standard knee-joint examination, namely 25
minutes. Controls were left unexposed. Directly after exposure
to the EMF, the joints of both groups were opened aseptically;
cartilage samples were obtained [13] and washed twice in
PBS (GibcoBRL, Life Technologies, Paisley, Renfrewshire,
UK). Afterwards, one part of these tissue explants was distrib-
uted into 24-well plates (Costar, Cambridge, MA, USA), in
quadruplicate at 100 to 150 mg of cartilage wet weight per
well, for isotope incorporation assays. The ratio of medium to
tissue (1.5 ml per 100 mg of cartilage) was always kept con-
stant [13,14]. The other part of the cartilage samples was
used for mRNA isolation, alkaline phosphatase assays, and
cell death assays; to this end, tissue was digested for 8 hours
in 0.2% collagenase B (Roche Diagnostics GmbH, Penzberg,
Germany) and filtered through a cell strainer (Falcon; Becton
Dickinson Labware, Lincoln Park, NJ, USA) to remove debris
and undissociated cell clusters. Evaluation of the chondrocyte
number was performed after trypan blue staining in a Bürker–
Türk chamber.
In some experiments, time-course analyses were performed
after the exposure of cartilage explants to the 3-tesla MRI
device or the 1.5-tesla device (using a standard protocol for
routine knee-joint examination). Metacarpophalangeal joints of
3-month-old calves and adult steers were opened aseptically
and cartilage samples (100 to 150 mg of cartilage wet weight)
were grown in 24-well plates in quadruplicate in serum-free
basal medium (BM). The serum-free BM consisted of DMEM/
Ham's F-12 (1:1) with ITS plus culture supplement (Collabo-
rative Biomedical Products, Bedford, MA, USA), α-ketoglutar-
ate (100 µM), caeruloplasmin (0.25 U/ml), cholesterol (5 µg/
ml), phosphatidylethanolamine (2 µg/ml), α-tocopherol acid
succinate (0.9 µM), reduced glutathione (10 µg/ml), taurine
(1.25 µg/ml), triiodothyronine (1.6 nM), hydrocortisone (1 nM),
parathyroid hormone (0.5 nM), β-glycerophosphate (10 mM
final concentration) and L-ascorbic acid 2-sulfate (50 µg/ml)
( S i g m a  C h e m i c a l  C o . ,  S t  L o u i s ,  M O ,  U S A )  [ 1 5 ]  a n d  w a s
shown to be appropriate for chondrocyte cultures by the
method of Erlacher and colleagues [16]. The explant cultures
were allowed to adjust to the culture settings for 24 hours.
After the BM had been changed after 24 hours, half of the
explant cultures were exposed to the EMFs exactly as
described above; untreated cultures served as controls. Sub-
sequently, the explants were subjected to [35S]sulfate incor-
poration assays, as well as RNA isolation directly after
exposure to the EMF (day 0) as well as on days 3 and 6.
All cultures were maintained at 37°C in humidified air contain-
ing 5% CO2.
Biosynthesis of macromolecules
Cartilage specimens were labelled in 1 ml of BM containing
20 µCi/ml of [35S]sulfate (carrier-free; Amersham, Little Chal-
font, Buckinghamshire, UK) for 4 hours at 37°C. After radiola-
beling, the explants were washed three times with ice-cold
buffer (10 nM EDTA, 0.1 M sodium phosphate, pH 6.5) fol-
lowed by digestion overnight in 1 ml of sodium phosphate
wash buffer containing proteinase K (1 mg/ml) at 80°C. Unin-
corporated isotope was removed by Sephadex G-25 gel chro-
matography on a PD-10 column (Pharmacia Biotech,
Piscataway, NJ, USA). Values were obtained by liquid-scintil-Available online http://arthritis-research.com/content/8/4/R106
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lation counting (1410 liquid-scintillation counter; Wallac Oy,
Turku, Finland) of aliquots from void volume fractions and nor-
malized to hydroxyproline content [17], because the basal
turnover of the collagen network is known to be very low in
articular cartilage [18,19] and was assumed to remain unaf-
fected during the study period. Additionally, the DNA content
of the digested samples was assessed with the use of bisben-
zimide (Hoechst 33258; Sigma) in accordance with estab-
lished protocols [20].
Histologic analysis
Tissue punches including cartilage and subchondral bone
from the control (n = 5) and 'pulsed EMF' (n = 5) groups were
fixed in 10% formalin, embedded in paraffin and sectioned at
5 µm. After deparaffination the sections were stained with tolu-
idine blue in accordance with standard protocols. To distin-
guish differences in metachromasia in the different sections,
digitized images were analyzed for intensity of staining. By the
use of Quantity One v. 4.5.2 software (Bio-Rad Laboratories,
Hercules, CA, USA), we determined color densities of 20 ran-
domly selected areas of both the pericellular and the territorial/
interterritorial zones on a total cartilage area of 0.25 mm2 for
each specimen. The densities of the pericellular zones were
then normalized to the densities of the territorial/interterritorial
zones.
RNA isolation and RT–PCR
For total RNA extraction, chondrocytes were isolated from car-
tilage explants of 100 to 150 mg wet weight per specimen in
0.2% collagenase B for 8 hours. The extraction of total RNA
was performed with a commercially available kit (RNeasy; Qia-
gen, Valencia, CA, USA) in accordance with the manufac-
turer's protocols.
RT–PCR was used to determine the presence of aggrecan,
type II collagen, osteocalcin (OC), osterix, runx2/cbfa1 and IL-
1β mRNA. Total RNA (1 µg) from each sample was copied
into cDNA in a 20 µl reaction by using the First-Strand cDNA
Synthesis Kit (Amersham Biosciences). Aliquots of 1 µl were
amplified in a 10 µl reaction mixture that contained 50 mM
Tris-HCl pH 8.3, 2 mM MgCl2, 0.25% bovine serum albumin,
2.5% Ficoll 400, 5 mM tartrazine, 200 µM dNTPs, each primer
at 1 µM, and 0.2 U Taq polymerase (Boehringer Mannheim,
Mannheim, Germany). The reaction profile as employed here
comprised an initial denaturation at 94°C for 2 minutes, fol-
lowed by 35 cycles (aggrecan, IL-1β)/33 cycles (type II colla-
gen)/32 cycles (osteocalcin, osterix, runx2/cbfa1)/25 cycles
(β-actin) at 94°C for 45 seconds, 55°C for 45 seconds, and
72°C for 55 seconds, and an additional extension step of 5
minutes at 72°C after the last cycle. Amplification reactions
were performed in an air thermal cycler (Mastercycler; Eppen-
dorf AG, Hamburg, Germany). Reaction products were ana-
lyzed by electrophoresis in 1.5% agarose gels. The amplified
DNA fragments were detected with a Fluorimager (Bio-Rad
Laboratories) and band densities were calculated with Quan-
tity One software (Bio-Rad Laboratories). Negative controls in
which cDNA was omitted from the reaction, as well as positive
controls (human articular cartilage for aggrecan and type II col-
lagen, peripheral blood mononuclear cells for IL-1β, and
bovine periosteum for osteocalcin, osterix and runx2/cbfa1)
were run in parallel. Primer sequences used were as follows:
aggrecan (470 bp), 5'-TCC CAG AAT CCA GCG GTG AGA
G-3' (forward) and 5'-GCA CAG GGC TTG AGG ATT CG-3'
(reverse) [21]; type II collagen (593 bp), 5'-TCG GGG CTC
CCC AGT CGC TGG TG-3' (forward) and 5'-GAT GGA GAA
CCT GGT ACC CCT GGA-3' (reverse) [22]; osteocalcin
(362 bp), 5'-GAC AGA CAC ACC ATG AGA ACC-3' (for-
Figure 1
Effects of a 3-tesla electromagnetic field on glycosaminoglycan synthesis Effects of a 3-tesla electromagnetic field on glycosaminoglycan synthesis. (a) Bovine metarcarpophalangeal joints (n = 5) were exposed to a 3-tesla 
electromagnetic field (EMF); untreated joints (n = 5) served as controls (control). Cartilage samples were obtained aseptically from the joints and 
labeled with [35S]sulfate for 4 hours. The incorporated radiolabel into the newly synthesized matrix macromolecules was then measured and normal-
ized to hydroxyproline content of the explants. Results are means and SD. *p < 0.0002 versus 'pulsed EMF'. (b) Subsequently, sulfated gly-
cosaminoglycans in the supernatant of the explant cultures were measured. Results are means and SD.Arthritis Research & Therapy    Vol 8 No 4    Sunk et al.
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ward) and 5'-CTA GCT CGT CAC AGT CAG GG-3' (reverse)
[23]; osterix (358 bp), 5'-GCAGCTAGAAGGGAGTGGTG-3'
(forward) and 5'-GCAGGCAGGTGAACTTCTTC-3' (reverse)
[24]; runx2/cbfa1 (270 bp), 5'-CCCCACGACAACCGCAC-
CAT-3' (forward) and 5'-CACTCCGGCCCACAAATC-3'
(reverse) [25]; IL-1β (394 bp), 5'-AAA CAG ATG AAG AGC
TGC ATC CAA-3' (forward) and 5'-CAA AGC TCA TGC AGA
ACA CCA CTT-3' (reverse) [26]; β-actin (520 bp), 5'-TGT
GAT GGT GGG AAT GGG TCA G-3' (forward) and 5'-TTT
GAT GTC ACG CAC GAT TTC C-3' (reverse).
Alkaline phosphatase activity
After digestion with collagenase, the isolated cells were dis-
tributed in 24-well plates in quadruplicate at a density of 105
cells/cm2 and then sonicated in 500 µl of 0.1% Triton X-100
in distilled water. Aliquots (100 µl) of each sample were incu-
bated with 100 µl of alkaline phosphatase substrate buffer
(100 mM diethanolamine, 150 mM NaCl, 2 mM MgCl2) con-
taining the soluble, chromogenic alkaline phosphatase sub-
strate p-nitrophenyl phosphate (2.5 µg/ml) for 5 to 25 minutes
at room temperature. The reaction was stopped with 50 µl of
1 M NaOH/0.1 M EDTA. Measurement was performed with an
ELISA Reader (MR 7000; Dynatech, Guernsey, Channel
Islands, UK) at 405 nm. Enzyme activity was expressed as
nmoles of p-nitrophenol released, normalized to the protein
content of the sample. Monolayer cultures of bovine periosteal
cells incubated with 10% FBS (PAA Laboratories, Linz, Aus-
tria) served as positive controls. Total cellular protein was
determined with the Bio-Rad protein assay in accordance with
the manufacturer's instructions (Bio-Rad Laboratories GmbH,
Munich, Germany); the absorbance of samples was measured
at 550 nm.
TdT-mediated dUTP nick end labeling and Annexin V 
assays
For cell death assessment we used the terminal deoxynucle-
otidyl-transferase (TdT)-mediated dUTP nick end labeling
technique (TUNEL; In Situ Cell Death Detection Kit with fluo-
rescein; Roche Diagnostics GmbH) and the Annexin V-FITS
assay (Alexis Austria, Vienna, Austria). Cartilage samples were
digested in collagenase B as described above. Chondrocytes
(106 per sample) were cultured for a further 24 hours in 50 ml
tubes in BM.
For TUNEL assays the cells were washed three times with
PBS and finally suspended in 100 µl of PBS in Micronic Tubes
(Micronic System, Lelystad, The Netherlands). Cells were
fixed and permeabilized with the Fix&Perm cell permeabiliza-
tion kit (An der Grub Inc., Kaumberg, Austria). In brief, after the
addition of 100 µl of fixation solution and incubation for 1 hour
at 20°C the samples were centrifuged at 300 g for 10 minutes.
The supernatant was discarded and 100 µl of the permeabili-
zation solution was added to the tubes. Subsequently, 50 µl of
TUNEL reaction mixture was added and the suspension was
incubated for 1 hour at 37°C. Thereafter, samples were ana-
lyzed on a FACScan (Becton Dickinson, Evembadegen, Bel-
gium) by dual-color immunocytofluorimetry [27].
Additionally we investigated cell death in cartilage sections
from the control (n = 5) and 'pulsed EMF' (n = 5) groups by
using the In-Situ Cell Death Detection Kit with fluorescein
(Roche Diagnostics GmbH) in accordance with the manufac-
turer's instructions. The sections were evaluated by fluores-
cence microscopy (Axioskop 2 mot plus; Zeiss, Oberkochen,
Germany).
For the Annexin V-FITS assays, 106 chondrocytes per sample
were washed three times with PBS and subsequently sus-
pended in 195 µl of PBS. Annexin V-FITS labeling buffer (5 µl)
was added and the samples were left to rest for 10 minutes
before resuspension in 200 µl of binding buffer. A 10 µl aliquot
of propidium iodide solution was added. The samples were
analyzed by dual-color cytofluorimetry [27].
Statistical analysis
Data are expressed as means ± SD. Statistical analysis was
performed with Student's t  test to compare treated with
untreated samples. Statistical significance was defined as p <
0.05.
Results
The exposure of whole joints to a 3-tesla EMF affects 
cartilage biosynthetic activity
Because low-energy EMFs have been reported to increase
cartilage matrix synthesis, we investigated the effects of a
high-energy 3-tesla EMF on the biosynthetic activity of articu-
lar cartilage. Metacarpophalangeal joints of 3-month-old
calves were subjected to a 3-tesla EMF (3 T constant plus a
Figure 2
Histological sections of bovine articular cartilage and histochemical  comparison Histological sections of bovine articular cartilage and histochemical 
comparison. Metacarpophalangeal joints derived from 3-month-old 
calves were subjected to a 3-tesla electromagnetic field (EMF) (n = 5) 
or were left untreated (n = 5). Thereafter, tissue punches including car-
tilage and subchondral bone were prepared for histological analysis 
and stained with toluidine blue in accordance with standard protocols. 
The figure shows two representative sections: (a) control; (b) cartilage 
after exposure to a 3-tesla EMF. Scale bars, 100 µm.Available online http://arthritis-research.com/content/8/4/R106
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0.0135 T pulse every 0.5 s) has been corrected. As a func-
tional reflection of biosynthesis, cartilage explants were sub-
jected to [35S]sulfate incorporation assays to evaluate the
neosynthesis of sulfated glycosaminoglycans (sGAGs). More-
over, their RNA was isolated and subjected to RT–PCR to
determine changes in gene expression for the major cartilage
proteins aggrecan and collagen II as well as for the cytokine
IL-1β.
Exposure to the 3-tesla EMF resulted in an unexpected
decrease in total sGAG synthesis compared with unexposed
controls. In the control group a mean [35S]sulfate incorpora-
tion rate of 3,068.6 ± 973.1 (mean ± SD) c.p.m./µg of hydrox-
yproline was measured, whereas in the 'pulsed EMF' sample
group we observed a marked decrease in isotope uptake
(1,588.9 ± 559.1 c.p.m./µg of hydroxyproline). This decrease
was highly significant compared with the control group (p <
0.0002) and reflected a decrease in sulfate incorporation of
48% (Figure 1a). In addition, a histochemical comparison of
cartilage sections after staining with toluidine blue revealed a
less intense staining of the pericellular zones in the 'pulsed
EMF' group than in controls (Figure 2). When we normalized
the densities of the pericellular zones to those of the territorial/
interterritorial zones we found a significant decrease (p  <
0.0002) in the 'pulsed EMF' group (1.36 ± 0.21 integrated
optical density) in comparison with the control group (1.47 ±
0.18 integrated optical density).
Given the detrimental effects of the 3-tesla EMF on sGAG syn-
thesis in articular cartilage, RT–PCR was performed to quan-
tify the gene expression of both aggrecan and type II collagen,
the major cartilage matrix components. As shown in Figure 3,
in the 'pulsed EMF' group aggrecan was highly downregulated
compared with untreated controls (p < 0.0002), supporting
the data on [35S]sulfate incorporation. The mRNA expression
of type II collagen was not significantly changed after exposure
to the 3-tesla EMF (p = 0.09; Figure 3).
To determine whether these findings reflected a decrease in
cellular activity or an increase in catabolic activity, the expres-
sion of IL-1β, an important cytokine in cartilage biology [28]
was measured, as was the release of sGAGs into the culture
supernatant. The exposure to the EMF did not lead to an over-
expression of IL-1β mRNA; rather – and in accordance with
the decrease in overall biosynthetic activity – we found a
decrease in IL-1β expression in the 'pulsed EMF' group (p <
0.02) when band densities were normalized to those of β-actin
(Figure 3). In line with this finding, there was no significant dif-
ference in sGAG content in the culture supernatant (p = 0.27)
between the 'pulsed EMF' group (196.7 ± 15.6 c.p.m./µg of
hydroxyproline) and the control group (215.8 ± 18 c.p.m./µg
of hydroxyproline) and thereby no evidence for a major loss of
sGAGs from the cartilage matrix (Figure 2b).
These results suggest a decrease in biosynthetic activity,
according to the sGAG synthesis rate, of articular chondro-
Figure 3
Expression of the cartilage markers aggrecan and collagen type II and also of IL-1β Expression of the cartilage markers aggrecan and collagen type II and also of IL-1β. Unexposed cultures served as negative controls (control). mRNA 
was obtained as described in the Materials and methods section. The presence of aggrecan, type II collagen and IL-1β, was detected by RT–PCR. 
The bar graphs show the integrated optical density of the bands after normalization to β-actin. Values are means and SD. Aggrecan: *p < 0.0002 
control versus 'pulsed EMF'; IL-1β: **p < 0.02 control versus 'pulsed EMF'.Arthritis Research & Therapy    Vol 8 No 4    Sunk et al.
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cytes after exposure to the 3-tesla EMF rather than a loss of
matrix macromolecules driven by catabolic events induced by
IL-1β or other molecules.
Exposure to a 3-tesla EMF does not induce cell death in 
articular chondrocytes
A decrease in cartilage biosynthesis could be caused by cell
death of resident cells, leading to a decrease in chondrocyte
numbers, which could have explained the results described
above. To determine a possible effect of a 3-tesla EMF on cell
survival, we assessed cell death rate and cellular DNA content
in chondrocytes after exposure to a 3-tesla EMF.
Chondrocytes subjected to the EMF showed no increased cell
death rate compared with controls, as shown by cytofluorime-
try (Annexin V; control group 7.8 ± 0.9 versus 'pulsed EMF'
group 8.8 ± 2.8% gated cells; TUNEL, control group 0.8 ± 0.4
versus 'pulsed EMF' group 0.9 ± 0.2% gated cells). In addi-
tion, in histological sections we found no increased cell death
rate in the 'pulsed EMF' group compared with the control
group by labeling of DNA strand breaks with the use of TUNEL
technology (Figure 4). Furthermore, there was no difference in
the DNA content of the cartilage samples (p = 0.9) between
the control group (0.9 ± 0.27 ng/ml per µg of hydroxyproline)
and the 'pulsed EMF' group (0.9 ± 0.37 ng/ml per µg of
hydroxyproline).
Impairment of chondrocyte activity induced by the 3-
tesla EMF is transient
According to the cell death and DNA data, there was no
detectable cell damage after exposure to EMF. We therefore
investigated whether the pulsed EMF led to a persistent
decrease in the metabolic activity of cartilage or whether the
decreased metabolic rate recovered from the effects of the
pulsed EMF, regaining its basal biosynthetic activity. For this
purpose we used cartilage explant cultures from metacar-
pophalangeal joints of calves (young group) and adult steers
(old group) which were subjected to the pulsed EMF; controls
were left unexposed. On days 0, 3 and 6 after exposure the
rate of newly synthesized matrix macromolecules was meas-
ured. In line with the above data obtained after the exposure of
whole joints to the pulsed EMF, we found a marked decrease
in total sGAG synthesis in both groups on day 0 after expo-
sure to the EMF: in the young group, control samples yielded
a mean isotope uptake rate of 836 ± 205.8 c.p.m./µg of
hydroxyproline, whereas in the EMF-treated samples the rate
was 352 ± 160.9 c.p.m./µg of hydroxyproline (48% decrease,
p < 0.0001; Figure 5a). Cartilage samples derived from adult
steer joints also displayed a significant decrease in sGAG bio-
synthesis after exposure to the pulsed EMF (control group,
391.1 ± 107.8 c.p.m./µg of hydroxyproline; 'pulsed EMF'
group, 262.2 ± 50.9 c.p.m./µg of hydroxyproline; p < 0.008;
Figure 5b), indicating a 33% decrease in isotope uptake and
thus shows the susceptibility to EMF also of adult cartilage.
Figure 4
Detection of cell death in articular chondrocytes after being subjected to a 3-tesla electromagnetic field Detection of cell death in articular chondrocytes after being subjected to a 3-tesla electromagnetic field. Sections from articular cartilage (n = 5) 
were assessed for cell death rate after exposure to a 3-tesla pulsed electromagnetic field (EMF) by using a direct TUNEL labeling assay and were 
compared with a control group (n = 5) that was left unexposed. Fluorescein-dUTP (green) and nuclear staining with 4',6-diamidino-2-phenylindole 
(DAPI; blue) reflect no difference in cell death rate between the control and the 'pulsed EMF' group. The figure shows one representative experi-
ment. DNAse-1-treated articular cartilage served as positive control. Scale bars, 100 µm.Available online http://arthritis-research.com/content/8/4/R106
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Importantly, however, articular chondrocytes recovered from
the EMF effects: on day 3, 'pulsed EMF' juvenile cartilage syn-
thesized a mean of 810.9 ± 281.9 c.p.m./µg of hydroxyproline
(control group 851.9 ± 205.6 c.p.m./µg of hydroxyproline, p =
0.65), and on day 6 the respective values were 1,070.8 ±
266.4 and 880.1 ± 187.9 c.p.m./µg of hydroxyproline (p <
0.02; Figure 5a). This ultimate increase in the 'pulsed EMF'
group might be interpreted as a reactive enhancement of
sGAG production after initial biosynthetic regress. Unlike the
metabolically highly active juvenile cartilage, adult tissue
showed no such 'rebound phenomenon': while the decrease
in biosynthetic activity of the samples paralleled the overall
results of young cartilage on day 0, biosynthesis was compa-
rable to controls on day 3 (control group, 454.4 ± 161.5
c.p.m./µg of hydroxyproline; 'pulsed EMF' group, 481.5 ±
151.1 c.p.m./µg of hydroxyproline; p = 0.81) and on day 6
(control group, 446.5 ± 111 c.p.m./µg of hydroxyproline;
'pulsed EMF' group, 394.5 ± 123.3 c.p.m./µg of hydroxypro-
line; p = 0.45; Figure 5b).
To determine whether these effects were a unique property of
high-energy fields, such as a 3-tesla EMF, we tested the influ-
ence of a 1.5-tesla EMF on matrix macromolecule neosynthe-
sis in adult bovine cartilage. Interestingly, in contrast to the 3-
tesla EMF, the 1.5-tesla field did not influence cartilage meta-
bolic activity (Figure 5c).
In parallel with sGAG synthesis, the mRNA expression of
aggrecan was assessed after exposure of explant cultures to
the 3-tesla EMF. In line with the data obtained for whole-joint
EMF exposure, in both the young (Figure 6a) and adult (Figure
6b) groups aggrecan gene expression was significantly down-
regulated on day 0 after being subjected to the 3-tesla EMF (p
< 0.009 and p < 0.02, respectively). The subsequent normal-
ization and even increase in sGAG synthesis at the end of the
culture period observed in the young group was also reflected
by a significant increase in aggrecan gene expression on day
6 (p < 0.05).
Whereas the endogenous expression of IL-1β was decreased
on day 0 in the young group, the old group displayed a delayed
response because IL-1β levels decreased on day 3 of the cul-
ture period. Collagen type II mRNA did not change signifi-
cantly in the young or in the old group (Figure 6).
Chondrocyte DNA content remained unaffected during the
experimental period in the young and in the old group (data not
shown).
Osteogenesis is not induced after exposure to the 3-
tesla EMF
Differentiation of fetal chondrocytes toward an osteogenic
phenotype under the influence of a high-energy EMF has been
described previously [29]. To determine the effects of a 3-
tesla EMF on possible osteogenic differentiation, we deter-
mined the endogenous expression of early and late markers of
osteogenic differentiation. We investigated the expression of
osterix, runx2/cbfa1 and osteocalcin and found no increase in
mRNA expression levels for osterix (control, 0.77 ± 0.02 inte-
grated optical density/β-actin; 'pulsed EMF', 0.69 ± 0.09 inte-
grated optical density/β-actin), runx2/cbfa1 (control, 0.79 ±
0.07 integrated optical density/β-actin; 'pulsed EMF', 0.82 ±
0.06 integrated optical density/β-actin) or osteocalcin (con-
trol, 0.98 ± 0.08 integrated optical density/β-actin; 'pulsed
EMF', 0.99 ± 0.2 integrated optical density/β-actin).
Additionally, alkaline phosphatase activity was measured
showing no increase in enyzmatic activity (control, 0.0069 ±
0.0017 nmol of p-nitrophenyl phosphate per minute per micro-
gram of protein; 'pulsed EMF', 0.0073 ± 0.0016 nmol of p-
nitrophenyl phosphate per minute per microgram of protein; p
= 0.6) under the influence of the 3-tesla EMF (not shown).
Discussion
The present study revealed the unexpected result of a signifi-
cant decrease in matrix macromolecule synthesis of cartilage
after exposure to a 3-tesla EMF. These data are based on the
sGAG synthesis rate in cartilage as well as gene expression
profiling of articular chondrocytes, demonstrating a decrease
in aggrecan mRNA synthesis, whether exposed to the high-
energy EMF as whole joint or as a cartilage explant. Because
lower-energy EMFs have not been shown to induce a
decrease in cartilage biosynthetic activity in this and previous
studies [5,6,30], the results obtained seem to be a conse-
quence of the exposure to a 3-tesla high-energy EMF.
It has been hypothesized that an EMF might act like a mechan-
ical load that causes a movement of fluid, which contains
charged particles, relative to the solid matrix structures such
as proteoglycans and collagens with their fixed charges
[9,10,31,32]. This fluid flow generates an electrical potential,
the so-called 'streaming potential' [33,34], which transduces
mechanical stress into an electrical phenomenon capable of
stimulating chondrocytes to synthesize matrix components.
Physiologically, mechanical stresses on cartilage range from
about 0 to 20 MPa [35] and stimulate the synthesis of matrix
constituents [36]; exceeding this threshold causes physical
damage to the cartilage [37-39]. Taking these facts into
account, a low-energy EMF may mimic mechanical stresses
within physiological amplitudes, potentially leading to cellular
stimulation [5-8], whereas a high-energy EMF is likely to
resemble stresses above physiological ranges, thereby initiat-
ing an inadequate flow of electrolytes and charges that ulti-
mately impair cartilage activity. This assumption is fostered by
our observations of a marked decrease in anabolic activity, as
shown by sGAG synthesis and aggrecan gene expression.
The studies of Lee and colleagues [40] and Trinidade and col-
leagues [41], who showed an impaired cartilage activity after
applying mechanical stresses, are in line with our findings.Arthritis Research & Therapy    Vol 8 No 4    Sunk et al.
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It is noteworthy that collagen type II expression was not appre-
ciably changed, which may be attributed to the very low basal
turnover of the collagen network [18,19]. Beyond that, the
release of sGAGs to the supernatant remained unchanged
from that in the controls, indicating no major catabolic activity.
Though not catabolic by itself, our inability to find increased
expression of IL-1β upon exposure of cartilage to high-energy
EMF is in line with the above results. A limiting factor to our
study could be the fact that tissue manipulation and digestion
can affect chondrocyte gene expression. Although the results
from the RT–PCR analysis support the [35S]sulfate incorpora-
tion data, the effects of the exposure to the EMF may have
been masked by changes in gene expression resulting from
enzymatic digestion and associated events. However, the
decrease in both anabolic and catabolic activity led us to
speculate that a high-energy EMF may to some extent compro-
mise the biosynthetic activity and/or function of articular
chondrocytes.
Although it is known that mechanical stress contributes to the
induction of chondrocyte cell death [42-44], in our experimen-
tal settings we found no difference in cell death rates between
EMF-exposed and control samples, either in TUNEL or in
Annexin V assays, which excludes cell death and a conse-
quent decrease in chondrocyte numbers as a cause of the
findings. Additionally, the 3-tesla EMF had no impact on the
DNA content of the cartilage specimens, making a loss of
chondrocytes very unlikely as a reason for the impaired biosyn-
thetic activity.
Whether the results obtained also relate to the situation in vivo
and in humans will have to be confirmed in similar analyses of
human cartilage or in animal studies. However, it is also
unknown whether this impairment of chondrocyte activity has
any implication for the development of cartilage damage as
seen in osteoarthritis. To address these questions, animal
studies or studies in humans, for instance by the delayed
gadolinium-enhanced MRI of cartilage (dGEMRIC) technique,
will be necessary.
The ability of articular chondrocytes to recover from mechani-
cal strains has been proposed previously [39,45]. When
investigating the effects of the 3-tesla EMF over a period of 6
days, we did in fact find a recovery of cartilage biosynthetic
activity. Furthermore, we tested whether there was a differ-
ence in the susceptibility to a high-energy EMF between young
and old cartilage. The results on sGAG and aggrecan mRNA
synthesis obtained on day 0 resembled the data from our initial
measurements, in both young and old samples. Subsequently,
the chondrocytes regained their biosynthetic activity over the
course of time. At the end of the culture period an increase in
sGAG/aggrecan mRNA production was found in the young
group but not in the adult group after EMF exposure. This
observation may be seen as a 'rebound phenomenon' caused
by a higher metabolic rate of these cells in young cartilage
compared to adult cartilage. In line with a lower metabolic
activity of old chondrocytes [46-48], such a rebound was not
seen in tissues from aged cartilage. Our data therefore sug-
gest that the effects of a 3-tesla EMF are transient and articular
chondrocytes recover from the initial impairment.
Conclusion
A high-energy EMF potentially impairs the biosynthetic activity
of articular chondrocytes; this effect is temporary, as shown
under the in vitro conditions employed here. Because no such
influence on articular cartilage could be seen after exposure to
Figure 5
Time course of effects of a 3-tesla electromagnetic field on glycosaminoglycan synthesis Time course of effects of a 3-tesla electromagnetic field on glycosaminoglycan synthesis. Cartilage explants derived from bovine metacarpophalan-
geal joints were incubated in serum-free basal medium (BM) and subjected to an electromagnetic field (EMF). The control group was left unexposed. 
The total proteoglycan synthesis rate was evaluated on days 0, 3 and 6 after exposure. Values were normalized to hydroxyproline content of the 
explants. Values are means and SD. (a) Exposure of juvenile bovine cartilage (n = 5) to a 3-tesla EMF. The white columns represent the unexposed 
controls (control), the grey columns the samples exposed to the EMF (pulsed EMF). *p < 0.0001 control versus 'pulsed EMF', **p < 0.02 'pulsed 
EMF' versus control. (b) Exposure of adult bovine cartilage (n = 3) to a 3-tesla EMF. The white columns represent the unexposed controls (control), 
the grey columns the samples exposed to the EMF (pulsed EMF). *p < 0.008 control versus 'pulsed EMF'. (c) To evaluate the effects of an EMF of 
less than 3 T, adult bovine cartilage (n = 5) was exposed to a 1.5-tesla EMF. The white columns represent the unexposed controls (control), the grey 
columns the samples exposed to the EMF. No significant difference between the groups could be determined.Available online http://arthritis-research.com/content/8/4/R106
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Figure 6
Time course of expression of aggrecan, type II collagen and IL-1β Time course of expression of aggrecan, type II collagen and IL-1β. The endogenous expression of aggrecan, type II collagen and IL-1β was assessed 
with RT–PCR on days 0, 3 and 6 after exposure to a 3-tesla electromagnetic field (EMF). Unexposed cultures served as controls (control). The inte-
grated optical density of the bands was determined and normalized to that of the β-actin bands as shown in the bar graphs. Values are means and 
SD. (a) mRNA was obtained from juvenile bovine cartilage samples (n = 4) Aggrecan: *p < 0.009 control versus 'pulsed EMF'; **p < 0.05 'pulsed 
EMF' versus control; IL-1β: *p < 0.03 control versus 'pulsed EMF'. (b) mRNA was obtained from adult bovine cartilage samples (n = 3). Aggrecan: 
#p < 0.02 control versus 'pulsed EMF'; IL-1β: #p < 0.02 control versus 'pulsed EMF'.Arthritis Research & Therapy    Vol 8 No 4    Sunk et al.
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a 1.5-tesla EMF, this impact on cellular activity seems to be a
characteristic of 3-tesla high-energy EMFs.
Our data therefore indicate that the assessment of muscu-
loskeletal structures with 3-tesla MRI devices may be accom-
panied by a transient disturbance in chondrocyte function after
exposure to the EMF. Given that cartilage with reduced bio-
synthetic activity may be deficient in its repair capacity,
patients may have to be advised to minimize their physical
activities for up to 72 hours after high-field MRI examination to
prevent possible damage to the articular cartilage.
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